Richard J. Rubino

2021

In 2021, Richard J. Rubino earned a total compensation of $1.3M as Former Chief Financial Officer, Secretary and Treasurer at Aerie Pharmaceuticals, a 24% decrease compared to previous year.

Compensation breakdown

Option Awards$606,793
Salary$283,751
Stock Awards$211,680
Other$179,772
Total$1,281,996

Rubino received $606.8K in option awards, accounting for 47% of the total pay in 2021.

Rubino also received $283.8K in salary, $211.7K in stock awards and $179.8K in other compensation.

Rankings

In 2021, Richard J. Rubino's compensation ranked 7,870th out of 12,405 executives tracked by ExecPay. In other words, Rubino earned more than 36.6% of executives.

ClassificationRankingPercentile
All
7,870
out of 12,405
37th
Division
Manufacturing
3,475
out of 5,494
37th
Major group
Chemicals And Allied Products
1,547
out of 2,369
35th
Industry group
Drugs
1,375
out of 2,090
34th
Industry
Biological Products, Except Diagnostic Substances
311
out of 452
31st
Source: SEC filing on April 26, 2022.

Rubino's colleagues

We found seven more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2021.

2021

Vicente Anido

Aerie Pharmaceuticals

Chief Executive Officer

2021

Raj Kannan

Aerie Pharmaceuticals

Chief Executive Officer

2021

Thomas Mitro

Aerie Pharmaceuticals

Chief Operating Officer

2021

Casey Kopczynski

Aerie Pharmaceuticals

Chief Innovation Officer, Head of Research and External Innovation

2021

John LaRocca

Aerie Pharmaceuticals

General Counsel

2021

Benjamin McGraw

Aerie Pharmaceuticals

Former Interim Executive Chair

2021

Christopher Staten

Aerie Pharmaceuticals

Chief Financial Officer

News

You may also like